Back to Search
MITCHELL SAUNDERS, MD
MD
Cardiovascular Disease Physician
NPI: 1770513863IndividualAccepts Medicare
Specialties, Licenses & Credentials
Nuclear Cardiology Physician
Nuclear Medicine — Nuclear Cardiology
Code: 207UN0901X
164946(NY)
Cardiovascular Disease PhysicianPrimary
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
164946(NY)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
STATE UNIVERSITY OF NEW YORK DOWNSTATE MEDICAL CENTER
Class of 1984
Research & Publications (20)
Effect of chemotherapeutic treatment on cytokine (IFN-gamma, IL-2, IL-4, IL-5, IL-10) gene transcription in response to specific antigens in Brugia malayi-infected Mastomys coucha.
PMID 18679719·Parasitol Res·2008
7-preclinical
Monitoring crystallisation of drugs from fast-dissolving oral films with isothermal calorimetry.
PMID 19596058·Int J Pharm·2009
4-observational
Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.
PMID 19652067·J Clin Oncol·2009
3-trial
Quantifying the "bio-" components in biophysical models of larval transport in marine benthic invertebrates: advances and pitfalls.
PMID 19556593·Biol Bull·2009
6-review
Response to Parnaby et al. (Defunctioning stomas in patients with locally advanced rectal cancer prior to preoperative chemoradiotherapy).
PMID 19508526·Colorectal Dis·2009
8-other
Carbohydrate and protein hydrolysate coingestions improvement of late-exercise time-trial performance.
PMID 19478339·Int J Sport Nutr Exerc Metab·2009
2-rct
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphoma.
PMID 19474785·Clin Pharmacol Ther·2009
8-other
Templating silver nanoparticle growth using phosphonated calixarenes.
PMID 19462091·Chem Commun (Camb)·2009
8-other
UGT1A1*28 genotype predicts gastrointestinal toxicity in patients treated with intermediate-dose irinotecan.
PMID 19450125·Pharmacogenomics·2009
8-other
Encapsulation and sustained release of curcumin using superparamagnetic silica reservoirs.
PMID 19396886·Chemistry·2009
8-other
Health literacy revisited: what do we mean and why does it matter?
PMID 19372101·Health Promot Int·2009
8-other
Australia's national men's health policy: masculinity matters.
PMID 19642955·Health Promot J Austr·2009
8-other
NMR temperature-jump method for measuring reaction rates: reaction of dimethylanthracene with H2@C60.
PMID 19348451·J Phys Chem A·2009
8-other
Characterization of biominerals in the radula teeth of the chiton, Acanthopleura hirtosa.
PMID 19292994·J Struct Biol·2009
7-preclinical
Ultrastructure of the epithelial cells associated with tooth biomineralization in the chiton Acanthopleura hirtosa.
PMID 19284897·Microsc Microanal·2009
7-preclinical
Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers.
PMID 19221750·Cancer Chemother Pharmacol·2009
4-observational
Testing strategies for the safety of nanoparticles used in medical applications.
PMID 19663587·Nanomedicine (Lond)·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1320 STONY BROOK RD BUILDING D SUITE 100
STONY BROOK, NY 11790 - Phone
- (631) 941-2273
Quick Facts
- NPI
- 1770513863
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile